↓ Skip to main content

Bumetanide for the treatment of seizures in newborn babies with hypoxic ischaemic encephalopathy (NEMO): an open-label, dose finding, and feasibility phase 1/2 trial

Overview of attention for article published in Lancet Neurology, May 2015
Altmetric Badge

About this Attention Score

  • In the top 5% of all research outputs scored by Altmetric
  • High Attention Score compared to outputs of the same age (97th percentile)
  • High Attention Score compared to outputs of the same age and source (93rd percentile)

Mentioned by

news
7 news outlets
blogs
1 blog
twitter
13 tweeters
patent
3 patents
facebook
2 Facebook pages

Citations

dimensions_citation
183 Dimensions

Readers on

mendeley
201 Mendeley
citeulike
2 CiteULike
You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output. Click here to find out more.
Title
Bumetanide for the treatment of seizures in newborn babies with hypoxic ischaemic encephalopathy (NEMO): an open-label, dose finding, and feasibility phase 1/2 trial
Published in
Lancet Neurology, May 2015
DOI 10.1016/s1474-4422(14)70303-5
Pubmed ID
Authors

Ronit M Pressler, Geraldine B Boylan, Neil Marlow, Mats Blennow, Catherine Chiron, J Helen Cross, Linda S de Vries, Boubou Hallberg, Lena Hellström-Westas, Vincent Jullien, Vicki Livingstone, Barry Mangum, Brendan Murphy, Deirdre Murray, Gerard Pons, Janet Rennie, Renate Swarte, Mona C Toet, Sampsa Vanhatalo, Sarah Zohar

Abstract

Preclinical data suggest that the loop-diuretic bumetanide might be an effective treatment for neonatal seizures. We aimed to assess dose and feasibility of intravenous bumetanide as an add-on to phenobarbital for treatment of neonatal seizures.

Twitter Demographics

The data shown below were collected from the profiles of 13 tweeters who shared this research output. Click here to find out more about how the information was compiled.

Mendeley readers

The data shown below were compiled from readership statistics for 201 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
Germany 2 <1%
United States 2 <1%
Finland 1 <1%
Austria 1 <1%
United Kingdom 1 <1%
India 1 <1%
Unknown 193 96%

Demographic breakdown

Readers by professional status Count As %
Researcher 30 15%
Student > Master 23 11%
Student > Bachelor 23 11%
Student > Ph. D. Student 22 11%
Professor > Associate Professor 16 8%
Other 53 26%
Unknown 34 17%
Readers by discipline Count As %
Medicine and Dentistry 59 29%
Neuroscience 31 15%
Agricultural and Biological Sciences 18 9%
Nursing and Health Professions 10 5%
Pharmacology, Toxicology and Pharmaceutical Science 9 4%
Other 27 13%
Unknown 47 23%

Attention Score in Context

This research output has an Altmetric Attention Score of 75. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 20 October 2022.
All research outputs
#473,044
of 22,509,254 outputs
Outputs from Lancet Neurology
#303
of 3,587 outputs
Outputs of similar age
#6,094
of 246,261 outputs
Outputs of similar age from Lancet Neurology
#4
of 61 outputs
Altmetric has tracked 22,509,254 research outputs across all sources so far. Compared to these this one has done particularly well and is in the 97th percentile: it's in the top 5% of all research outputs ever tracked by Altmetric.
So far Altmetric has tracked 3,587 research outputs from this source. They typically receive a lot more attention than average, with a mean Attention Score of 31.3. This one has done particularly well, scoring higher than 91% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 246,261 tracked outputs that were published within six weeks on either side of this one in any source. This one has done particularly well, scoring higher than 97% of its contemporaries.
We're also able to compare this research output to 61 others from the same source and published within six weeks on either side of this one. This one has done particularly well, scoring higher than 93% of its contemporaries.